# LAMZEDE
> **BLA761278** · Biologics License Application · Sponsor: CHIESI FARMACEUTICI SPA · Approved 2023-02-16
## Drug
- **FDA Application Number:** BLA761278
- **Application type:** Biologics License Application
- **Brand name:** LAMZEDE
- **Generic name:** VELMANASE ALFA-TYCV
- **Active ingredients:** VELMANASE ALFA-TYCV
- **Dosage form:** POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER
- **Route:** —
- **Marketing status:** Prescription
- **Sponsor:** CHIESI FARMACEUTICI SPA
- **Manufacturer:** Chiesi USA, Inc.
- **First approval:** 2023-02-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761278)
---
*MORVS · CC0 1.0*